ATP and Biolojic Design Launch Aulos Bioscience to Develop Highly Differentiated IL-2 Antibody Approach to Fighting Cancer
Immuno-oncology spinout from Biolojic Design created with $40M Series A financing from ATP
Immuno-oncology spinout from Biolojic Design created with $40M Series A financing from ATP